Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Findings from papers in eBioMedicine advance development of IAVI’s single-dose Lassa fever vaccine candidate 

April 16, 2025

Nonhuman primates protected from Lassa fever; high-resolution images show how vaccine-induced antibodies bind to the viral surface.

Read more

Features

IAVI at the World Vaccine Congress Washington 2025

April 16, 2025

IAVI leaders to guide urgent dialogue on R&D for vaccines and antibodies in a dynamic global health landscape.

Read more

In The News

Vaccine profiles: Ebola

Gavi

April 16, 2025

Read more

Features

IAVI and Japan’s premier global health organization pilot Human Resource Development Program

April 1, 2025

Visiting scientist Taka Funaki learned about IAVI’s discovery, regulatory, manufacturing, and clinical trial expertise in the program’s first two-week exchange.

Read more

In The News

Fruits of Decades of AIDS Vaccine Research Imperiled by Trump’s Withdrawal of US Funding

Bloomberg

March 28, 2025

Read more

In The News

High hopes for major TB vaccine study recently launched in Paarl

Spotlight

March 26, 2025

Read more

In The News

Are new TB vaccines finally within reach?

VaccinesToday

March 24, 2025

Read more

Advancing access to monoclonal antibodies in Africa: setting priorities, assessing feasibility, and enabling R&D and manufacturing

This meeting report synthesizes key learnings and recommendations from a 2023 workshop on advancing access to monoclonal antibodies (mAbs) in Africa conducted jointly by the Africa Centres for Disease Control and Prevention and IAVI, with the support of Wellcome. The workshop was held as an official side meeting of the 3rd International Conference of Public Health in Africa.

Read more